Firmagon 120mg Injection

About

Firmagon 120mg Injection contains Degarelix, a gonadotropin-releasing hormone (GnRH) receptor antagonist. Unlike GnRH agonists, which initially cause a surge in testosterone before downregulation, Degarelix directly and rapidly blocks GnRH receptors in the pituitary gland. This immediate blockade prevents the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), leading to a rapid and sustained reduction in testosterone production by the testes. This mechanism is crucial in managing hormone-sensitive prostate cancer.

By quickly lowering testosterone levels, Firmagon helps to control the growth and spread of prostate cancer cells, which are often dependent on testosterone for their proliferation. It is administered as a subcutaneous injection and is indicated for the treatment of advanced hormone-dependent prostate cancer, offering a rapid onset of action in achieving medical castration.

Uses

• Treatment of advanced hormone-dependent prostate cancer
• Rapid reduction of testosterone levels
• Alternative to surgical castration
• Management of prostate cancer where GnRH agonists are contraindicated

Directions For Use

This medication is administered via subcutaneous injection by a healthcare professional. The initial loading dose is followed by maintenance doses as prescribed by your doctor.

Benefits

• Rapid reduction in testosterone levels
• Effective in controlling advanced prostate cancer
• Avoids the initial testosterone flare associated with GnRH agonists
• May improve quality of life for patients
• Offers a non-surgical option for medical castration
• Well-tolerated in many patients

Side Effects

• Injection site reactions (pain, redness, swelling)
• Hot flashes
• Weight gain
• Fatigue
• Elevated liver enzymes
• Anemia
• Musculoskeletal pain
• Headache
• Dizziness
• Nausea
• Diarrhea
• Increased sweating

Safety Measures

• Alcohol - Moderate alcohol consumption is generally acceptable, but excessive intake may exacerbate hot flashes or other side effects.
• Pregnancy - Firmagon is not indicated for use in women. It is contraindicated in pregnant women due to potential harm to the fetus.
• Breastfeeding - Firmagon is not indicated for use in women. It is contraindicated in breastfeeding women.
• Liver - Use with caution in patients with pre-existing liver disease. Liver function tests should be monitored periodically during treatment.
• Kidney - No dose adjustment is typically required for mild to moderate renal impairment. Use with caution in severe renal impairment.
• Lung - No specific lung-related precautions are generally noted for Firmagon. However, any new or worsening respiratory symptoms should be reported to a doctor.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.